Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)

作者: E Van Cutsem , M Dicato , J Wils , D Cunningham , E Diaz-Rubio

DOI: 10.1016/S0959-8049(02)00122-3

关键词:

摘要: This article summarises the progress that has been made in adjuvant treatment of colorectal cancer over last decade. In view consequent improvements recurrence rates and overall survival, development effective treatments for is considered as one most important to be clinical oncology Treatment recommendations based on evidence-based data expert opinions are summarised this manuscript. However, a consensus cannot reached all aspects because currently emerging will influence practice many ongoing trials. Those involved should therefore encouraged continue provide optimal patient care participate well designed trials order increase evidence upon which they can base their judgements make further progress.

参考文章(42)
Survival after postoperative combination treatment of rectal cancer. The New England Journal of Medicine. ,vol. 315, pp. 1294- 1295 ,(1986) , 10.1056/NEJM198611133152014
Matthias Lorenz, Hans-Helge Müller, Harald Schramm, Heinz-Jochen Gassel, Hans-Günther Rau, Karsten Ridwelski, Johann Hauss, Rudolf Stieger, Karl-Walter Jauch, Wolf O. Bechstein, Albrecht Encke, Randomized Trial of Surgery Versus Surgery Followed by Adjuvant Hepatic Arterial Infusion With 5-Fluorouracil and Folinic Acid for Liver Metastases of Colorectal Cancer Annals of Surgery. ,vol. 228, pp. 756- 762 ,(1998) , 10.1097/00000658-199812000-00006
Improved survival with preoperative radiotherapy in resectable rectal cancer. The New England Journal of Medicine. ,vol. 336, pp. 980- 987 ,(1997) , 10.1056/NEJM199704033361402
Guido Francini, Roberto Petrioli, Luciano Lorenzini, Sergio Mancini, Salvatore Armenio, Gabriello Tanzini, Stefania Marsili, Antonietta Aquino, Giuseppe Marzocca, Serenella Civitelli, Lorenzo Mariani, Domenico De Sando, Sergio Bovenga, Marco Lorenzi, Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer Gastroenterology. ,vol. 106, pp. 899- 906 ,(1994) , 10.1016/0016-5085(94)90748-X
C G Moertel, T R Fleming, J S Macdonald, D G Haller, J A Laurie, C M Tangen, J S Ungerleider, W A Emerson, D C Tormey, J H Glick, Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. Journal of Clinical Oncology. ,vol. 13, pp. 2936- 2943 ,(1995) , 10.1200/JCO.1995.13.12.2936
Norman Wolmark, Howard Rockette, Eleftherios Mamounas, Judy Jones, Sam Wieand, DL Wickerham, Harry D Bear, James N Atkins, Nikolay V Dimitrov, Andrew G Glass, Edwin R Fisher, Bernard Fisher, None, Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project C-04 Journal of Clinical Oncology. ,vol. 17, pp. 3553- 3559 ,(1999) , 10.1200/JCO.1999.17.11.3553
B. Glimelius, Chemoradiotherapy for rectal cancer - is there an optimal combination? Annals of Oncology. ,vol. 12, pp. 1039- 1045 ,(2001) , 10.1023/A:1011628524392
Jules E. Harris, Louise Ryan, Herbert C. Hoover, Robert K. Stuart, Martin M. Oken, Al B. Benson, Edward Mansour, Daniel G. Haller, Judith Manola, Michael G. Hanna, Adjuvant Active Specific Immunotherapy for Stage II and III Colon Cancer With an Autologous Tumor Cell Vaccine: Eastern Cooperative Oncology Group Study E5283 Journal of Clinical Oncology. ,vol. 18, pp. 148- 148 ,(2000) , 10.1200/JCO.2000.18.1.148
A de Gramont, J F Bosset, C Milan, P Rougier, O Bouché, P L Etienne, F Morvan, C Louvet, T Guillot, E François, L Bedenne, Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Journal of Clinical Oncology. ,vol. 15, pp. 808- 815 ,(1997) , 10.1200/JCO.1997.15.2.808